The alpha9 and alpha10 nicotinic cholinergic subunits assemble to form the receptor believed to mediate synaptic transmission between efferent olivocochlear fibers and hair cells of the cochlea, one of the few examples of postsynaptic function for a non-muscle nicotinic acetylcholine receptor (nAChR). However, it has been suggested that the expression profile of alpha9 and alpha10 overlaps with that of alpha7 in the cochlea and in sites such as dorsal root ganglion neurons, peripheral blood lymphocytes, developing thymocytes, and skin. We now report the cloning, total synthesis, and characterization of a novel toxin alpha-conotoxin PeIA that discriminates between alpha9alpha10 and alpha7 nAChRs. This is the first toxin to be identified from Conus pergrandis, a species found in deep waters of the Western Pacific. Alpha-conotoxin PeIA displayed a 260-fold higher selectivity for alpha-bungarotoxin-sensitive alpha9alpha10 nAChRs compared with alpha-bungarotoxin-sensitive alpha7 receptors. The IC50 of the toxin was 6.9 +/- 0.5 nM and 4.4 +/- 0.5 nM for recombinant alpha9alpha10 and wild-type hair cell nAChRs, respectively. Alpha-conotoxin PeIA bears high resemblance to alpha-conotoxins MII and GIC isolated from Conus magus and Conus geographus, respectively. However, neither alpha-conotoxin MII nor alpha-conotoxin GIC at concentrations of 10 microM blocked acetylcholine responses elicited in Xenopus oocytes injected with the alpha9 and alpha10 subunits. Among neuronal non-alpha-bungarotoxin-sensitive receptors, alpha-conotoxin PeIA was also active at alpha3beta2 receptors and chimeric alpha6/alpha3beta2beta3 receptors. Alpha-conotoxin PeIA represents a novel probe to differentiate responses mediated either through alpha9alpha10 or alpha7 nAChRs in those tissues where both receptors are expressed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1074/jbc.M504102200 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Using Constellation Pharmacology to Characterize a Novel α-Conotoxin from .
Mar Drugs
February 2024
School of Biological Sciences, University of Utah, Salt Lake City, UT 84112, USA.
The venom of cone snails has been proven to be a rich source of bioactive peptides that target a variety of ion channels and receptors. α-Conotoxins (αCtx) interact with nicotinic acetylcholine receptors (nAChRs) and are powerful tools for investigating the structure and function of the various nAChR subtypes. By studying how conotoxins interact with nAChRs, we can improve our understanding of these receptors, leading to new insights into neurological diseases associated with nAChRs.
View Article and Find Full Text PDFRational Design of Potent α-Conotoxin PeIA Analogues with Non-Natural Amino Acids for the Inhibition of Human α9α10 Nicotinic Acetylcholine Receptors.
Mar Drugs
February 2024
Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao 266003, China.
α-Conotoxins (α-CTxs) are structurally related peptides that antagonize nicotinic acetylcholine receptors (nAChRs), which may serve as new alternatives to opioid-based treatment for pain-related conditions. The non-natural amino acid analogues of α-CTxs have been demonstrated with improved potency compared to the native peptide. In this study, we chemically synthesized Dab/Dap-substituted analogues of α-CTx PeIA and evaluated their activity at heterologously expressed human α9α10 nAChRs.
View Article and Find Full Text PDFAnalgesic α-Conotoxin Binding Site on the Human GABA Receptor.
Mol Pharmacol
October 2022
Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, Australia (A.R.B., J.R.M., D.J.A.); School of Science, RMIT University, Melbourne, Australia (A.K., A.H.); and School of Health and Biomedical Sciences, RMIT University, Bundoora, Australia (A.R.W)
The analgesic -conotoxins Vc1.1, RgIA, and PeIA attenuate nociceptive transmission via activation of G protein-coupled GABA receptors (GABARs) to modulate N-type calcium channels in primary afferent neurons and recombinantly coexpressed human GABAR and Cav2.2 channels in human embryonic kidney 293T cells.
View Article and Find Full Text PDFInteraction of α9α10 Nicotinic Receptors With Peptides and Proteins From Animal Venoms.
Front Cell Neurosci
December 2021
Department of Molecular Neuroimmune Signaling, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.
Unlike most neuronal nicotinic acetylcholine receptor (nAChR) subunits, α7, α9, and α10 subunits are able to form functional homo- or heteromeric receptors without any β subunits. While the α7 subtype is widely distributed in the mammalian brain and several peripheral tissues, α9 and α9α10 nAChRs are mainly found in the cochlea and immune cells. α-Conotoxins that specifically block the α9α10 receptor showed anti-nociceptive and anti-hyperalgesic effects in animal models.
View Article and Find Full Text PDFAnalgesic α-conotoxins modulate native and recombinant GIRK1/2 channels via activation of GABA receptors and reduce neuroexcitability.
Br J Pharmacol
January 2022
Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW, Australia.
Article Synopsis
- Activation of GIRK channels by analgesic α-conotoxins like Vc1.1 and GABA receptors can reduce pain by inhibiting certain calcium channels in nerve cells.
- The study found that these α-conotoxins enhance potassium currents in specific cell models, demonstrating their ability to activate GIRK channels in response to GABA signaling.
- Ultimately, the research suggests that the mechanism behind the pain-relief effects of Vc1.1 and baclofen is related to their ability to reduce neuron excitability through GIRK channel potentiation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!